Isatuximab induces antitumor activity in blastic plasmacytoid dendritic cell neoplasm through cellular cytotoxicity - PubMed
6 hours ago
- #Isatuximab
- #BPDCN
- #Cellular Cytotoxicity
- Isatuximab demonstrates antitumor activity in blastic plasmacytoid dendritic cell neoplasm (BPDCN) via cellular cytotoxicity.
- The authors disclosed competing interests, including consultancy, research funding, and honoraria from various pharmaceutical companies for both DM and NY.